Search results for "ESMO"

showing 10 items of 135 documents

V2-receptor–mediated relaxation of human renal arteries in response to desmopressin

1999

The effects of deamino-8-D-arginine vasopressin (desmopressin), a V2 receptor antidiuretic agonist, were studied in isolated rings from branches of renal arteries obtained from 22 patients undergoing nephrectomy. The rings were suspended in organ bath chambers for isometric recording of tension. In precontracted rings with norepinephrine (10(-6) to 3 x 10(-6) mol/L), desmopressin (10(-11) to 3 x 10(-7) mol/L) caused endothelium-dependent relaxation (81%+/-4% reversal of the initial contraction in arteries with endothelium; 20%+/-4% in arteries without endothelium; P < .05). The relaxation to desmopressin in rings with endothelium was reduced significantly by indomethacin (10(-6) mol/L) and …

AdultMaleAgonistReceptors VasopressinVasopressinmedicine.medical_specialtymedicine.drug_classMuscle RelaxationIndomethacinIn Vitro TechniquesRenal AgentsMuscle Smooth VascularRenal ArteryIsometric ContractionArginine vasopressin receptor 2Internal medicineInternal MedicinemedicineHumansCyclooxygenase InhibitorsDeamino Arginine VasopressinEnzyme InhibitorsDesmopressinReceptorAgedVasopressin receptorbusiness.industryAntidiuretic Hormone Receptor AntagonistsMiddle AgedVasodilationNG-Nitroarginine Methyl EsterEndocrinologyCirculatory systemProstaglandinsFemaleNitric Oxide SynthasebusinessAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsmedicine.drugAmerican Journal of Hypertension
researchProduct

Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin

1997

Purpose: The goal of this study was to determine the effects of vasopressin and the selective V 2 -receptor agonist desmopressin on human saphenous veins, with special emphasis on endothelium-mediated responses. Methods: Human saphenous vein segments were obtained from 35 patients undergoing coronary bypass surgery. Paired segments, one normal and the other deendothelized by gentle rubbing, were mounted for isometric recording of tension in organ baths. Concentration-response curves to vasopressin and desmopressin were determined in the presence and in the absence of either the V,-receptor antagonist d(CH 2 ) 5 Tyr(Me)AVP (10 −6 mol/L), the V 1 -V 2 receptor antagonist desGly-d(CH 2 ) 5 D-T…

AdultMaleAgonistReceptors Vasopressinmedicine.medical_specialtyVasopressinVasopressinsmedicine.drug_classVasodilator AgentsIndomethacinVasodilationHormone AntagonistsVasotocinIsometric ContractionInternal medicinemedicineHumansVasoconstrictor AgentsCyclooxygenase InhibitorsDeamino Arginine VasopressinSaphenous VeinEnzyme InhibitorsDesmopressinReceptorAgedDose-Response Relationship Drugbusiness.industryAntagonistMiddle AgedReceptor antagonistArginine VasopressinNG-Nitroarginine Methyl EsterEndocrinologyProstaglandinsFemaleSurgeryEndothelium VascularNitric Oxide Synthasemedicine.symptombusinessCardiology and Cardiovascular MedicineAntidiuretic Hormone Receptor AntagonistsVasoconstrictionhormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Vascular Surgery
researchProduct

The use of esmolol in whole-body hyperthermia: Cardiovascular effects

1997

Whole-body hyperthermia (WBH) is a well-described investigational adjunct to systemic chemotherapy for the treatment of advanced malignancies. The hemodynamic consequences of this physiologic state may include tachycardia, which can produce acute myocardial ischemia in patients with coronary artery disease. Ischemic heart disease is currently considered a contraindication to WBH. We chose to investigate the consequences of using a new beta 1-adrenergic antagonist, esmolol, to attempt to control the tachycardia associated with WBH. After institutional approval and patient consent, nine consecutive patients with normal cardiac function presenting for WBH with carboplatin infusion were studied…

AdultMaleCancer ResearchMean arterial pressureCardiac outputHeart diseasePhysiologySinus tachycardiaAdrenergic beta-AntagonistsCardiac indexAntineoplastic AgentsCoronary DiseaseCarboplatinPropanolaminesHeart RateNeoplasmsTachycardiaPhysiology (medical)Heart rateHumansMedicineInfusions Intravenousbusiness.industryContraindicationsHemodynamicsHyperthermia InducedMiddle Agedmedicine.diseaseEsmololCombined Modality TherapyAnesthesiaHeart failureFemaleSafetymedicine.symptombusinessmedicine.drugInternational Journal of Hyperthermia
researchProduct

Aging changes of the ciliary epithelium border layers and their significance for intraocular pressure.

1971

AdultMaleIntraocular pressureAgingBasement MembraneAqueous HumorMedicineHumansIntraocular PressureAgedbusiness.industryCiliary BodyInfantCiliary epitheliumEpithelial CellsAnatomyDesmosomesFibroblastsMiddle AgedElastic TissueCapillariesOphthalmologyMicroscopy ElectronFemaleCollagenbusinessAmerican journal of ophthalmology
researchProduct

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

2007

Objectives: To investigate efficacy, safety, and impact on quality of sleep of desmopressin in the treatment of nocturia. Methods: Adults aged >= 18 yr with nocturia (>= 2 voids/night) received desmopressin tablets (0.1, 0.2, or 0.4 mg) during a 3-wk dose-titration period. Patients should show sufficient response during the dose-titration period (>= 20% reduction in nocturnal diuresis) and a return of nocturnal diuresis to >= 80% of baseline levels during washout. Eligible patients then entered a 3-wk double-blind treatment period and received either desmopressin or placebo. Results: 127 patients were randomised to either desmopressin (n = 61) or placebo (n = 66). Twenty (33%) desmopressin-…

AdultMaleNephrologymedicine.medical_specialtyUrologyPlacebo-controlled studyAdministration OralDiuresisPlaceboDouble-Blind MethodInternal medicinemedicineHumansNocturiaDeamino Arginine VasopressinDesmopressinAdverse effectAgedAged 80 and overDose-Response Relationship Drugbusiness.industryAntidiuretic AgentsMiddle AgedSurgeryUrodynamicsTreatment OutcomeAnesthesiaFemaleNocturiamedicine.symptomSleepbusinesshormones hormone substitutes and hormone antagonistsFollow-Up Studiesmedicine.drugAntidiureticEuropean Urology
researchProduct

Intermediate filaments and desmosomal plaque proteins in testicular seminomas and non-seminomatous germ cell tumours as revealed by immunohistochemis…

1987

Seminomas and non-seminomatous testicular germ cell tumours were studied for the presence of cytokeratin and vimentin filaments and desmosomes using immunohistochemical methods. In the majority of the classical seminomas and in seminomatous areas of mixed tumours most tumour cells appeared to lack cytokeratin filaments. Some seminomas contained a focally variable proportion of cells exhibiting cytokeratin-positive structures while other cases contained only few seminoma cells with a well developed fibrillar cytokeratin network. Gel electrophoresis of cytoskeletal proteins from microdissected regions revealed cytokeratin polypeptides nos. 8 and 18 typical of simple epithelia. In one seminoma…

AdultMalePathologymedicine.medical_specialtyendocrine system diseasesAdolescentIntermediate FilamentsFluorescent Antibody TechniqueVimentinmacromolecular substancesAntigen-Antibody ComplexDysgerminomaBiologyurologic and male genital diseasesAntibodiesPathology and Forensic MedicineEmbryonal carcinomaCytokeratinTesticular NeoplasmsmedicineCarcinomaHumansVimentinIntermediate filamentMolecular BiologyCytoskeletonDesmoplakinMembrane ProteinsCell BiologyGeneral MedicineSeminomaDesmosomesmedicine.diseaseCytoskeletal ProteinsMicroscopy Electronmedicine.anatomical_structureDesmoplakinsbiology.proteinKeratinsGerm cellVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in pati…

2012

Summary Von Willebrand disease (VWD) is an inherited bleeding disorder caused by the quantitative or qualitative deficiency of von Willebrand factor (VWF). Replacement therapy with plasma-derived VWF/factor VIII (FVIII) concentrates is required in patients unresponsive to desmopressin. To assess the efficacy, safety and ease of use of a new, volume-reduced (VR) formulation of VWF/FVIII concentrate Haemate® P in patients requiring treatment for bleeding or prophylaxis for recurrent bleeding or for invasive procedures. Pharmacoeconomic variables were also recorded. Data were analysed using descriptive statistics. This was a multicentre, prospective, observational study. Consecutively enrolled…

AdultMalePediatricsmedicine.medical_specialtyAdolescentBlood Loss SurgicalSevere diseaseHemorrhageSettore MED/15 - Malattie Del SangueYoung AdultVon Willebrand factorCost of Illnesshemic and lymphatic diseaseshemophiliavon Willebrand FactorVon Willebrand diseasemedicineHumansIn patientProspective StudiesDesmopressinAdverse effectChildGenetics (clinical)AgedFactor VIIIbiologybusiness.industryDrug SubstitutionAnticoagulantsHematologyGeneral MedicineMiddle Agedmedicine.diseaseResponse to treatmentHospitalizationvon Willebrand DiseasesItalyChild Preschoolbiology.proteinPasteurizationObservational studyFemalebusinessmedicine.drug
researchProduct

Study of abnormal adrenal receptors in subjects with ACTH-independent Cushing's syndrome and nodular adrenal hyperplasia

2020

ACTH-independent Cushing's Syndrome (AICS) accounts for 15-20% of cases of Cushing's syndrome, with1% due to abnormal receptors. Our aim is to study the presence of abnormal receptors in subjects diagnosed with AICS with nodular adrenal hyperplasia in a 14-year period (2002-2016), as well as its clinical-biological and evolutive characteristics.A multicentre descriptive study of a 15-case series of AICS with nodular adrenal hyperplasia (study period: 2002-2016). In these cases, abnormal receptor screening was performed by means of stimulation tests, with a plasma cortisol increase of ≥ 25% from baseline being considered pathologic.Of the 15 cases, 13 were female, with a mean age at diagnosi…

AdultMalemedicine.medical_specialtyMetoclopramide030209 endocrinology & metabolism030204 cardiovascular system & hematologyGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineAdrenal GlandsmedicineMeal testHumansDesmopressinReceptorCushing SyndromeAgedHyperplasiaS syndromebusiness.industryMiddle AgedHyperplasiamedicine.diseaseFemaleBilateral adrenalectomyTerlipressinbusinessmedicine.drugEndocrinología, Diabetes y Nutrición (English ed.)
researchProduct

Management of fibro-osseous lesions of the craniofacial area: presentation of 19 cases and review of the literature

2013

Introduction: Fibro-osseous lesions constitute a rare benign type of pathology with a non-odontogenic lineage that affect the craniofacial area. According to Waldrom’s classification, these lesions are divided into: fibrous dysplasia (FD), cemento-ossifying fibroma (COF) and desmoplastic fibroma (DF). Material and Methods: A retrospective study was performed on patients diagnosed with fibro-osseous lesions of the craniofacial area at the Hospital Universitario La Fe, Valencia, during 1987-2009. A total of 19 cases were collected: 15 cases compatible with an FD diagnosis, 3 cases with a COF diagnosis and 1 case with a DF diagnosis. Results: In the differential diagnosis, entities having simi…

AdultMalemedicine.medical_specialtyPathologyBone NeoplasmsOdontologíaFibrous Dysplasia PolyostoticAsymptomaticFacial BonesLesionYoung AdultDesmoplastic fibromamedicineHumansCraniofacialChildGeneral DentistryAgedRetrospective Studiesbusiness.industryFibrous dysplasiaSkullReview-ArticleFibroma DesmoplasticRetrospective cohort studyFibrous Dysplasia of BoneMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesOtorhinolaryngologyChild PreschoolFibroma OssifyingUNESCO::CIENCIAS MÉDICASFemaleSurgeryRadiologyOral Surgerymedicine.symptomFibromaDifferential diagnosisbusiness
researchProduct

Desmopresssin and hemodilution: implications in doping.

2009

Blood doping improves physical performance in sport. This is the reason why the antidop- ing authorities subject athletes to blood tests. Plasma volume expanders are prohibited agents used to reduce an artifi cial increase in hemato- logical values using diff erent illegal practices. The aim of our study was to test whether desmo- pressin (DDAVP)-induced hemodilution would alter the concentration of hematological param- eters used to detect blood doping in sports. This was an intra-subject crossover study. Venous blood samples were obtained from eight physi- cally active males on two occasions. On the fi rst o ccasion the subjects ingested 1.5 L of mineral water and 4.3 μ g / kg of DDAVP. O…

AdultMalemedicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationHematocritchemistry.chemical_compoundHemoglobinsYoung AdultBlood dopingInternal medicinemedicineHumansOrthopedics and Sports MedicineDeamino Arginine VasopressinDesmopressinDoping in SportsCreatinineHemodilutionCross-Over Studiesmedicine.diagnostic_testbusiness.industryAntidiuretic AgentsAlbuminVenous bloodCrossover studySubstance Abuse DetectionEndocrinologychemistryHematocritHemoglobinbusinessmedicine.drugSportsInternational journal of sports medicine
researchProduct